D. N. Davidyuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
D. N. Davidyuk has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Han Yuyao
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Igor Vladimirovich Reshetov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
2 shared publications - Precious Tochukwu Nwodo
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Svetlana I. Samoylova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Tat'YAna Aleksandrovna Demura
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Xu Shijun
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications
Latest Publications
- 16 October 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (5) , 81-86
Clinical and morphological characteristics and prognostic significance of the immune microenvironment and the level of PD-L1 expression in squamous cell carcinoma of the tongue and oropharynx
Squamous cell carcinoma of the tongue and oropharynx is characterized by significant clinical and biological heterogeneity, highlighting the need for reliable prognostic and predictive biomarkers. This review analyzes current evidence regarding the significance of programmed death-ligand 1 (PD-L1) expression and immune microenvironment characteristics in these malignancies. PD-L1 has been shown to play a central role in tumor immune evasion; however, its prognostic value remains controversial and appears to depend on human papillomavirus (HPV) status, tumor immune contexture, and methodological approaches used for assessment. More consistent associations with clinical outcomes have been demonstrated for immune infiltration parameters, including high densities of CD8+ T lymphocytes, abundant tumor-infiltrating lymphocytes, and a favorable balance between effector and regulatory immune cells. The combined assessment of PD-L1 expression, immune microenvironment features, and HPV status may improve patient stratification and facilitate personalized treatment strategies. Further studies are required to standardize PD-L1 evaluation methods and to develop integrated prognostic models incorporating molecular and immunological biomarkers.
- 16 October 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (5) , 81-86
Clinical and morphological characteristics and prognostic significance of the immune microenvironment and the level of PD-L1 expression in squamous cell carcinoma of the tongue and oropharynx
Squamous cell carcinoma of the tongue and oropharynx is characterized by significant clinical and biological heterogeneity, highlighting the need for reliable prognostic and predictive biomarkers. This review analyzes current evidence regarding the significance of programmed death-ligand 1 (PD-L1) expression and immune microenvironment characteristics in these malignancies. PD-L1 has been shown to play a central role in tumor immune evasion; however, its prognostic value remains controversial and appears to depend on human papillomavirus (HPV) status, tumor immune contexture, and methodological approaches used for assessment. More consistent associations with clinical outcomes have been demonstrated for immune infiltration parameters, including high densities of CD8+ T lymphocytes, abundant tumor-infiltrating lymphocytes, and a favorable balance between effector and regulatory immune cells. The combined assessment of PD-L1 expression, immune microenvironment features, and HPV status may improve patient stratification and facilitate personalized treatment strategies. Further studies are required to standardize PD-L1 evaluation methods and to develop integrated prognostic models incorporating molecular and immunological biomarkers.
- Open Access
- 13 March 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (1) , 95-110
Prognostic significance of CD44 and CK19 expression in head and neck squamous cell carcinoma
Прогностическая значимость исследований CD44 и CK19 при плоскоклеточном раке головы и шеи
- 13 March 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (1) , 95-110
Open AccessPrognostic significance of CD44 and CK19 expression in head and neck squamous cell carcinoma
Прогностическая значимость исследований CD44 и CK19 при плоскоклеточном раке головы и шеи